Roxifiban Acetate

N/A

Report date: 2026/02/03 17:04:33

Base Information

Drug NameRoxifiban Acetate
Drug Alias Name้†‹้…ธ็ฝ—ๆ˜”้ž็ญ็ฝ—ๆ˜”้ž็ญLumaxisDMP-754
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsThrombosisPeripheral Arterial Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsThrombosisPeripheral Arterial Disease

Other Information

ATC CodeN/A
Related LinksKEGG